Aussies need a nationally consistent vaccination approach

Following a decline in vaccination rates following the peak of the COVID-19 pandemic, a new report is calling for a united, consistent, national approach to vaccinate Australians following a decline in vaccination rates after the peak of the COVID-19 pandemic. The Grattan Institute’s ‘A fair shot: How to close the vaccination gap’ report suggests taking…

Read More

VIVA! Communications clinches Best PR Campaign – Awareness and Advocacy with Edwards Lifesciences at the 2022 PRIME Awards

VIVA! Communications marked the 18th annual PRIME Awards in style last night (Thursday, November 10, 2022) together with our much-valued clientele, Edwards Lifesciences and Dr Falk Pharma,  and Australian representatives from the pharmaceutical industry, at the Sofitel Wentworth Sydney Hotel.   Hosted by comedian, musician and former member of ABC TV’s satirical program, The Chaser,…

Read More

Seqirus joins international vaccine venture to develop long-lasting, universal flu vaccine

Seqirus (owned by CSL) has joined an international, non-profit venture dedicated to decoding the immune system to develop a universal flu vaccine that affords long-lasting protection against seasonal and pandemic influenza across demographics and geography. The Human Vaccines Project aims to decode the human immune system to accelerate development of vaccines and immunotherapies against major…

Read More

Influencing the public debate around flu vaccination: a case study

Last month, VIVA! Communications successfully collaborated with the Pharmacy Guild of Australia (PGA) to release new research regarding the attitudes of Australian adults toward flu vaccination. Alarmingly, it was revealed that one-in-two Australian adults do not plan to vaccinate against the flu this year. Alongside this, the research uncovered that many do not understand the…

Read More